Summary: Atlas Ocular’s Bahram Alavi announces the launch of the revolutionary Apollo Amniotic Membrane Graft Technology, designed to enhance ocular healing through its anti-scarring, anti-inflammatory, and healing-promoting properties. This product leverages over a century of research and is available exclusively to physicians.
Bethesda, MD, [2024] — Atlas Ocular, a leading biotechnology company specializing in ophthalmic and optometric solutions, is excited to announce the launch of the groundbreaking Apollo Amniotic Membrane Graft Technology. This innovative product, spearheaded by Atlas Ocular’s founder and president, Bahram (Ben) Alavi, promises to revolutionize the treatment of various ocular conditions through its advanced healing properties.
Apollo Amniotic Membrane Graft Technology
Derived from human placental tissue, the Apollo Amniotic Membrane Graft is harvested during live, scheduled cesarean section births from pre-consenting mothers. With over a century of research supporting the healing properties of amniotic membranes, this product leverages these innate benefits to offer anti-scarring, anti-inflammatory, and healing-promoting effects.
Extensively tested by an independent laboratory, the Apollo Allograft’s bioactivity has been validated, confirming the presence of growth factors and cytokines essential for the healing process. Available in various sizes, Bahram Alavi emphasizes the Apollo product is designed for comfort and ease of use. Upon application, it is covered with a bandage contact lens, and it naturally incorporates and dissolves into the cornea within 3-5 days, during which significant improvement is expected. Patients typically have a follow-up appointment 4-6 days post-placement to remove the bandage lens and assess healing progress.
The Apollo Amniotic Membrane Graft is a therapeutic solution available exclusively to physicians. Healthcare providers interested in incorporating this advanced technology into their practice can contact Atlas Ocular for ordering information.
About Atlas Ocular
Founded in 2018 in Bethesda, Maryland, Atlas Ocular is dedicated to developing biological products that harness the body’s natural healing abilities. The company focuses on the ophthalmic and optometric fields, delivering innovative solutions that improve patient outcomes through superior technology and exceptional customer service. For more information, visit atlasocular.com.
About Ben Alavi
Bahram (Ben) Alavi, the visionary founder and president of Atlas Ocular, brings over 20 years of experience in the healthcare and medical device industries. Beginning his career at Medtronic, Bahram Alavi was inspired by his father, a renowned orthopedic surgeon and professor at Tehran University. His father’s advice, “no matter what you do in life, do it to the best of your ability,” continues to drive the ethos of Atlas Ocular, fostering a culture of excellence in technology and customer care.
